KA

Kanchan Ashwinbhai Parsana

Active Director Director DIN 10211193
DIN 10211193 First appointment Jun 2023 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Kanchan Ashwinbhai Parsana

Data last updated:

Kanchan Ashwinbhai Parsana is a Director at Xiphoid Pharmaceuticals Private Limited (since 2023). The company operates in Trading.

DIN 10211193
Primary Designation Director
Industry Trading
First Appointment 19 Jun 2023
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Jun 20232022Active

Directorship timeline

Open interactive timeline →
Xiphoid Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kanchan Ashwinbhai Parsana

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kanchan Ashwinbhai Parsana

Kanchan Ashwinbhai Parsana currently holds 1 directorship: Xiphoid Pharmaceuticals Private Limited (Director, since 19 Jun 2023).

Kanchan Ashwinbhai Parsana was first appointed on 19 Jun 2023 as Director at Xiphoid Pharmaceuticals Private Limited.

The current boards of Kanchan Ashwinbhai Parsana's companies include Ashvin Nathabhai Parsana (Xiphoid Pharmaceuticals Private Limited), Dilipbhai Laxmanbhai Dudhagara (Xiphoid Pharmaceuticals Private Limited), Dimpalben Sanjaybhai Chovatiya (Xiphoid Pharmaceuticals Private Limited), Ruchi Sharma (Xiphoid Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available